Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study
Patients with inflammatory bowel disease (IBD) often have associated conditions, for which anti-inflammatory medication with cyclo-oxygenase (COX) inhibitors may be helpful. The current evidence is conflicting regarding the role of COX-inhibitors in causing relapse in IBD. This case-control study ex...
Main Authors: | Abigail Hensley, Ian L. P. Beales |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/8/3/512 |
Similar Items
-
CYCLO-OXYGENASE 2 IS PRESENT IN THE MAJORITY OF LESIONAL SKIN FROM PATIENTS WITH AUTOINMUNE BLISTERING DISEASES
by: Ana Maria Abreu Velez, et al.
Published: (2013-10-01) -
Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs
by: Abdulwahed Al-Saeed
Published: (2011-11-01) -
Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
by: Yehyun Park, et al.
Published: (2022-10-01) -
Dihydroartemisinin Regulates the Th/Treg Balance by Inducing Activated CD4+ T cell Apoptosis via Heme Oxygenase-1 Induction in Mouse Models of Inflammatory Bowel Disease
by: Si Chao Yan, et al.
Published: (2019-07-01) -
Steroid resistance in inflammatory bowel disease
by: A. G. Kharitonov, et al.
Published: (2016-09-01)